Paraguay Medical Device Registry Teardown: DINAVISA Database Analysis
A quantitative analysis of Paraguay's DINAVISA medical device registro sanitario database: 8,162 registrations, product-type split, and leading holders.
Paraguay Medical Device Registry Teardown
For medical device and IVD manufacturers targeting expansion in South America, Paraguay represents a stable, digitally accessible market. As a member of the MERCOSUR trade bloc, Paraguay aligns its medical device sanitary registration (registro sanitario) framework with regional standards, making it a critical entry point for regional market access. The Dirección Nacional de Vigilancia Sanitaria (DINAVISA), under the Ministry of Public Health and Social Welfare (MSPBS), regulates all medical devices, diagnostics, and healthcare equipment.
A quantitative teardown of the compiled DINAVISA sanitary registration database (snapshot compiled on June 22, 2026) reveals several key structural metrics:
- Total Medtech Registrations: 8,162 registrations across 8,008 unique product names.
- Unique Registration Holders: 365 local companies are authorized to hold registrations.
- Product-Type Split: General medical devices, sharps, and personal protective equipment (DM) lead with 4,640 records (56.8%), followed by In Vitro Diagnostics (IV) with 2,007 records (24.6%), and Class I medical devices (DMNSO) with 1,515 records (18.6%).
- Registration-Holder Concentration: The market is relatively fragmented compared to smaller Balkan registries. INDEX SACI is the leading holder with 423 registrations (5.2%), followed by EL ALAMO S.A. with 347 (4.3%), MEDICAL SUPPLY S.A. with 292 (3.6%), DENT-PAR S.A. with 226 (2.8%), and Chaco Internacional S.A. with 213 (2.6%). Together, the top five holders control 1,501 registrations, or 18.4% of the database.
- Therapeutic Specialists: Dental and IVD specialist holders are prominent. Dental Guaraní S.A. holds 171 registrations and Roche Diagnostics Paraguay S.A. holds 170 registrations, indicating highly active sub-segments.
- Register Cleanliness: The database is highly current. Of the 3,360 registrations carrying an explicit expiry date, only 46 had expired prior to the snapshot date, indicating a clean and active registry.
This teardown sizes the Paraguayan medical device database, breaks down product categories, maps registration holder concentration, and translates this data into concrete distribution decisions. Regionally, this analysis pairs with our Argentina ANMAT medical device register market analysis, our Colombia IMPORTER and APODERADO concentration analysis, and our Ecuador ARCSA medical device register analysis.
Methodology Note: This analysis is based on the June 22, 2026 compiled snapshot of the DINAVISA medical device registro sanitario data accessed via the DINAVISApy public consultation portal. Counts are computed directly from the register extract by MedDeviceGuide. Proportional splits (product types, holder concentration) represent the durable structural characteristics of the Paraguayan market. Only 3,360 of the 8,162 records carry an explicit expiry date; active/expired calculations are restricted to this dated subset.
Paraguay's Regulatory Framework: DINAVISA and MERCOSUR Alignment
DINAVISA (Dirección Nacional de Vigilancia Sanitaria) is the competent authority in Paraguay responsible for the evaluation, registration, control, and surveillance of medicines, medical devices, and other healthcare products. Founded to ensure the safety and quality of medical products, DINAVISA has undergone significant digital modernization, consolidating its processes into the DINAVISApy portal.
Paraguay's medical device framework is structured around the following rules:
- MERCOSUR Harmonization: Paraguay's risk classification matches the MERCOSUR four-tier system (Class I, II, III, and IV), which aligns with the EU GHTF rules. Class I represents low-risk devices, while Class IV represents high-risk implants or active devices.
- Mandatory Local Registration Holder (Titular de Registro): Foreign manufacturers cannot hold a registro sanitario directly. They must appoint a local Registration Holder (Titular del Registro), which must be a legally established company in Paraguay holding a valid establishment license (Habilitación de Empresa) issued by DINAVISA.
- Sanitary Registry Requirements (SG 669/16): Technical file requirements are governed by Ministry of Health Resolution SG 669/16. Submissions must include the Free Sale Certificate (FSC) from the country of origin, QMS certification (ISO 13485 or MERCOSUR GMP), technical specifications, labeling, and Instructions for Use (IFU) in Spanish.
- Registration Fees (SG 784/16): Government fees for registrations are structured by risk class under Resolution SG 784/16:
- Class I (Low Risk / DMNSO): Base fee of PYG 1,300,000 (approx. USD 170)
- Class II (Medium-Low Risk): Base fee of PYG 2,000,000 (approx. USD 260)
- Class III (Medium-High Risk): Base fee of PYG 3,300,000 (approx. USD 430)
- Class IV (High Risk): Base fee of PYG 5,000,000 (approx. USD 650)
- Note: These represent the official government base fees. Total project costs will include local representative service fees, translation costs, and testing/legalization fees.
- Validity and Renewal: Under Paraguay's current (2025) framework, registro sanitario certificates are valid for up to 10 years and are renewable for equal periods. Renewals must be submitted electronically through the DINAVISApy portal before expiry, ensuring no gap in market access.
How large is the Paraguay DINAVISA medical device database and how many registration holders does it contain?
The Paraguay DINAVISA database contains 8,162 registrations, covering 8,008 unique product names held by 365 unique registration holders.
The close alignment between total registrations (8,162) and unique product names (8,008) indicates a highly clean, non-replicated register. Unlike registries in Eastern Europe where the same product is frequently registered by multiple importers, the Paraguayan registry is structured around exclusive registrations: a single registro sanitario covers a specific commercial product for a single registration holder. This structure simplifies tracking but increases the importance of partner selection.
The register is maintained digitally, and as of June 2026, it represents a highly active database. A query of the dated subset (3,360 records with explicit expiry dates) shows that only 46 records had expired prior to the snapshot date. This 1.4% expiration rate indicates that the database contains current, active products rather than historical or inactive listings.
How are DINAVISA registrations split across medical devices, IVD, and Class I product types?
The DINAVISA database classifies products into three primary codes (sigla field):
- DM (Dispositivos Médicos): General medical devices, surgical instruments, sharps, and personal protective equipment.
- IV (In Vitro Diagnóstico): Reagents, calibrators, controls, and instruments used for laboratory diagnostics.
- DMNSO (Dispositivos Médicos No Sujetos a Registro Obligatorio): Class I (low-risk) medical devices that undergo a simplified notification process.
The distribution of these codes across the 8,162 registrations is as follows:
| Product Type (Code) | Number of Registrations | Percentage Share |
|---|---|---|
| General Medical Devices / Sharps / PPE (DM) | 4,640 | 56.8% |
| In Vitro Diagnostics (IV) | 2,007 | 24.6% |
| Class I / Simplified Notification (DMNSO) | 1,515 | 18.6% |
| Total | 8,162 | 100.0% |
General medical devices (DM) represent the majority of the market at 56.8%, reflecting steady demand for basic hospital consumables and surgical instruments.
In Vitro Diagnostics (IV) represents a significant 24.6% share, indicating that laboratory diagnostics is a highly active segment in Paraguay. Class I devices under the DMNSO notification pathway account for 18.6% of registrations. This split highlights that while high-risk devices require full registration, a substantial portion of the market is accessed through the simplified Class I notification route, which reduces time-to-market.
Detailed Document Checklist for DINAVISA Registration (Resolution SG 669/16)
To file a successful registration under Resolution SG 669/16, manufacturers must prepare a comprehensive technical dossier. The requirements differ by risk class, but the core checklist for Class II, III, and IV devices includes:
- Legal Documents:
- Power of Attorney (POA): Legally appointing the Paraguayan Titular del Registro, signed by the manufacturer, notarized, and apostilled.
- Free Sale Certificate (FSC): Issued by the competent authority of the country of origin (e.g., FDA, EU Competent Authority), verifying that the device is freely marketed, notarized, and apostilled.
- Establishment License (Habilitación): Valid license of the Paraguayan importer/holder showing authorization to store and distribute the specific class of devices.
- Technical Documentation:
- Device Description: Detailed commercial and technical description, including material composition, design, dimensions, and accessories.
- Conformity Assessment certificates: Valid CE certificate, FDA clearance letter, or equivalent regulatory proof.
- Instructions for Use (IFU) and Labeling: Must be translated into Spanish. The label must explicitly state the product name, manufacturer details, registry number, batch number, and expiry date.
- Quality and Safety Evidence:
- Quality Management System (QMS) Certification: ISO 13485 or MERCOSUR GMP (Buenas Prácticas de Fabricación) certificate.
- Biocompatibility Reports: Required for all patient-contacting devices in accordance with ISO 10993.
- Sterilization Validation: Documentation showing sterilization methods and validation parameters (for sterile devices).
- Stability and Shelf-Life Studies: Testing protocols and reports justifying the claimed expiry dates.
Quality Management Systems & MERCOSUR GMP Compliance
A major hurdle for high-risk device entry (Class III and IV) is the verification of Quality Management System (QMS) compliance. Paraguay, as a MERCOSUR member, enforces MERCOSUR GMP (Buenas Prácticas de Fabricación - BPF) standards, harmonized under MERCOSUR GMC Resolution No. 20/11:
- GMP Recognition: Paraguay recognizes QMS certifications issued by other MERCOSUR audit bodies, such as Brazil's ANVISA or Argentina's ANMAT. If a manufacturer has undergone an ANVISA or ANMAT audit and holds a valid MERCOSUR BPF certificate, DINAVISA will generally accept this document without requiring an independent audit.
- ISO 13485 Acceptance: For manufacturers outside MERCOSUR (e.g., in the US, Europe, or Asia), DINAVISA relies heavily on ISO 13485 certificates issued by accredited registrar bodies. This certificate must be accompanied by the establishment's QMS manual and summaries of recent internal and external audit reports.
- Local Storage Audits: Before a local registration holder can list a new device, their local warehouse must be inspected by DINAVISA to ensure compliance with storage and distribution standards (Buenas Prácticas de Almacenamiento y Distribución). The facility must feature temperature and humidity controls, quarantine zones, and computerized batch traceability.
Who are the leading sanitary-registration holders and how concentrated are they?
Foreign manufacturers must register their products through a local Registration Holder. An analysis of the registration_holder field across the 8,162 registrations reveals a fragmented distribution compared to other markets:
| Registration Holder | Number of Registrations | Percentage Share | Primary Specialization |
|---|---|---|---|
| INDEX SACI | 423 | 5.2% | General Medical / Disposables |
| EL ALAMO S.A. | 347 | 4.3% | Pharmaceuticals / Diagnostics |
| MEDICAL SUPPLY S.A. | 292 | 3.6% | General Medical Consumables |
| DENT-PAR S.A. | 226 | 2.8% | Orthodontic / Dental Materials |
| Chaco Internacional S.A. | 213 | 2.6% | Surgical Equipment / Implants |
| Dental Guaraní S.A. | 171 | 2.1% | Dental Equipment / Consumables |
| Roche Diagnostics Paraguay S.A. | 170 | 2.1% | Laboratory Diagnostics / IVD |
| Others (Long Tail) | 6,320 | 77.4% | Various |
| Total | 8,162 | 100.0% |
The top five registration holders control 1,501 registrations, or 18.4% of the database. The single largest holder, INDEX SACI, holds only 5.2% of registrations. The remaining 77.4% of the database is distributed among a long tail of 360 local distributors and agents.
This fragmentation has important implications for market entry:
- Low Channel Lock-In: Unlike registries in smaller Balkan states or Central America where a few distributors control over half of all registrations, Paraguay's registry is open. Manufacturers have a wide choice of potential partners.
- Specialist Competence: The presence of specialized holders like Dental Guaraní S.A. (2.1% share, focused on dental supplies) and Roche Diagnostics Paraguay S.A. (2.1% share, focused on IVD) shows that top-tier distributors specialize by therapeutic area. Broad-line distributors like INDEX and EL ALAMO focus on general medical consumables (DM).
- Appointing the Right Partner: Manufacturers must choose partners based on their therapeutic specialization rather than their size. A large generalist distributor may not have the clinical access required to sell specialized implants or capital equipment.
Vigilance and Post-Market Surveillance (PMS) in Paraguay
Once a medical device is listed in the DINAVISA database, the local Registration Holder becomes the legal representative responsible for Tecnovigilancia (medical device vigilance). The framework is designed to monitor safety profile performance after commercial release:
- Adverse Event Reporting: Local holders must report serious adverse events (defined as events leading to death or serious deterioration of health) to DINAVISA within 10 calendar days of becoming aware of the event. Non-serious events or near-misses must be reported within 30 days.
- Field Safety Corrective Actions (FSCA): If a manufacturer initiates a global product recall, field correction, or safety alert, the Paraguayan holder must submit the FSCA details to DINAVISA within 48 hours of notification. The submittal must outline the number of affected units imported into Paraguay, their current distribution status (in warehouses, hospitals, or with patients), and the plan for recall or correction.
- Vigilance Coordination: Manufacturers must establish clear communication channels with their Paraguayan holders. Because the holder is legally responsible under MSPBS rules, any delay in communication can result in administrative fines, suspension of the registro sanitario, or import blocks.
Public Healthcare Procurement and Tenders (MSPBS and IPS)
For most medtech companies, the public sector is the largest buyer in Paraguay. Public procurement is split between two primary entities:
- Ministerio de Salud Pública y Bienestar Social (MSPBS): Manages public hospitals and primary health centers, procuring medical consumables, vaccines, and equipment.
- Instituto de Previsión Social (IPS): The national social security health insurance system, which operates its own network of hospitals (including the Central Hospital in Asunción) and represents the largest individual buyer of medical technology and diagnostics.
The Role of the Registration Holder in Tenders
Under Paraguayan procurement law, only locally established companies with valid DINAVISA habilitación can bid in public tenders. Consequently, the foreign manufacturer's local Registration Holder acts as the bidder. Because the registration holder manages the bidding, the relationship between manufacturer and holder is highly interdependent. If the holder lacks the financial capacity or legal standing (e.g., due to tax issues or previous tender defaults), the manufacturer's products cannot participate in the tender, regardless of their quality or registration status. This makes vetting the local partner's tender track record a critical step during distributor due diligence.
Comparative Analysis: Paraguay vs. Latin American Regional Peers
To assist regulatory teams in regional planning, the table below compares Paraguay's DINAVISA registry with its peers in Argentina, Colombia, and Ecuador:
| Metric | Paraguay (DINAVISA) | Argentina (ANMAT) | Colombia (INVIMA) | Ecuador (ARCSA) |
|---|---|---|---|---|
| Total Registrations | 8,162 | ~23,000 | ~45,000 | 326,334 (listed items) |
| Unique Holders | 365 | ~800 | ~1,200 | ~2,500 |
| Top Holder Share | 5.2% (INDEX SACI) | ~4.0% | ~3.0% | ~2.5% |
| Top 5 Holder Share | 18.4% | ~15.0% | ~12.0% | ~10.0% |
| Primary Code Split | DM (57%), IV (25%), DMNSO (19%) | Risk Class (I-IV) | Importer/Holder | Risk Class |
| Regulatory Alliance | MERCOSUR | MERCOSUR / GHTF | Andean Community (CAN) | Andean Community (CAN) |
| Simplified Pathways | Class I Notification | CE / FDA Reliance | CE / FDA Reliance | Simplified notification |
| Digital Portal | DINAVISApy | Helena | SIVICOS | ARCSA-connected |
This comparative matrix highlights several key regional trends:
- Registry Size: Paraguay's registry of 8,162 registrations is smaller than Argentina's and Colombia's but is highly structured and digitized. It is significantly smaller than Ecuador's ARCSA database, which contains over 300,000 listed items due to bulk importing rules.
- Fragmentation: All four South American registries exhibit high fragmentation at the registration-holder level, with the top five holders in each country controlling under 20% of the market. This reflects a diverse distributor landscape across South America.
- Regulatory Alignment: Paraguay and Argentina share MERCOSUR alignment, allowing manufacturers to leverage their technical files and stability studies across both jurisdictions.
Strategic Market-Entry Playbook for Paraguay
For regulatory affairs managers planning entry into Paraguay, we recommend the following structured approach:
Step 1: Verify MERCOSUR Documentation
Ensure your device's technical dossier, stability studies, and risk analysis align with MERCOSUR requirements. If the device already has an ANMAT registration in Argentina or an ANVISA registration in Brazil, leverage these files to speed up DINAVISA submission.
Step 2: Choose the Correct Registration Holder
Evaluate potential partners based on their therapeutic area. For general consumables, large broad-line distributors are suitable. For specialized dental, orthopedic, or diagnostic products, target specialized holders (such as Dental Guaraní or Roche Diagnostics) who have established clinical relationships.
Step 3: Secure the Registration Rights
Although the Paraguayan holder landscape is fragmented, registration transfer is still legally regulated. Ensure your contract includes a clear "transfer-of-rights" clause, specifying that the local holder must transfer the registro sanitario to another entity at your request.
Step 4: Budget for Official Fees
Align your budget with the Resolution SG 784/16 fee schedule, ensuring fees are paid in Paraguayan Guaraní (PYG) via the DINAVISApy portal to avoid processing delays.
Step 5: Plan for Translation and Spanish Labeling
All labeling, packaging, and Instructions for Use (IFU) must be in Spanish. Working with local Spanish translators ensures compliance with DINAVISA labeling standards.
Frequently Asked Questions
Which agency maintains the medical device sanitary register in Paraguay?
The Dirección Nacional de Vigilancia Sanitaria (DINAVISA), under the Ministry of Public Health and Social Welfare (MSPBS) of Paraguay, maintains the sanitary register of medical devices and diagnostics.
Is a local registration holder mandatory to register a medical device in Paraguay?
Yes. Foreign manufacturers must appoint a local Registration Holder (Titular del Registro) based in Paraguay who holds a valid establishment license to register products with DINAVISA.
What are the registration fees for medical devices in Paraguay?
Under Resolution SG 784/16, base fees range from PYG 1,300,000 for Class I (DMNSO) products to PYG 5,000,000 for Class IV (high-risk) products.
How long are DINAVISA registrations valid?
Under Paraguay's current (2025) framework, DINAVISA registros sanitarios are valid for up to 10 years from the date of issue and must be renewed electronically prior to expiry.
How clean is the Paraguay DINAVISA database?
The database is highly active and clean. An analysis of registrations with expiry dates shows that only 1.4% had expired before June 2026, indicating that the database lists currently active products.
Conclusion
Paraguay's DINAVISA database represents a clean, digitized MERCOSUR registry of 8,162 registrations, split between general medical devices (56.8%), IVDs (24.6%), and Class I notifications (18.6%). The registration-holder landscape is fragmented, with the top five holders controlling only 18.4% of the market. This fragmentation allows manufacturers flexibility in partner selection, but requires careful evaluation of distributor capabilities by therapeutic specialty. By leveraging MERCOSUR alignment and securing registration transfer rights, manufacturers can establish a compliant and flexible market footprint in Paraguay.
This article is educational and does not constitute legal, regulatory, or clinical advice. Registration requirements change; verify current requirements directly with DINAVISA before acting.
Sources
- DINAVISA Public Consultation Portal (official): Dirección Nacional de Vigilancia Sanitaria,
dnvspy.mspbs.gov.py/dnvspy/reportes_publicos/consulta_publica_rs/consulta-publica-rs.html. - DINAVISA Official Web Portal (official): Ministry of Health, Paraguay,
dinavisa.gov.py. - Resolution SG 669/16 (official): Technical requirements for the registration of medical devices and diagnostics in Paraguay.
- Resolution SG 784/16 (official): Official fee schedule for sanitary registration and control in Paraguay.
- Paraguay Medical Device Registration Costs (consultancy): OMC Medical cost breakdown and timeline analysis,
omcmedical.com/blog/paraguay-medical-device-registration-costs. - How to Register Medical Devices in Paraguay (consultancy): Regdesk market access guide,
regdesk.co/blog/how-to-register-paraguay. - Register Data (dataset): MedDeviceGuide analysis of the DINAVISA registry public consultation extract, snapshot dated June 22, 2026.